Xtant Medical Holdings (XTNT) Short term Debt (2010 - 2025)

Xtant Medical Holdings (XTNT) has reported Short term Debt for 14 consecutive years, with $10.9 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, Short term Debt fell 10.42% year-over-year to $10.9 million in Q4 2025; TTM through Dec 2025 was $10.9 million, a 10.42% decrease from a year earlier, with the FY2025 full-year figure at $10.9 million, down 10.42% from the prior year.
• Short term Debt was $10.9 million for Q4 2025 at Xtant Medical Holdings, down from $11.3 million in the prior quarter.
• Over five years, Short term Debt peaked at $16.5 million in Q1 2021 and troughed at $1.3 million in Q3 2022.
• A 5-year average of $7.5 million and a median of $4.9 million in 2023 frame the typical range for Short term Debt.
• Across the five-year window, Short term Debt sank 78.45% in 2021 and surged 222.26% in 2024, its largest moves.
• Over 5 years, Short term Debt stood at $3.6 million in 2021, then slipped by 6.66% to $3.4 million in 2022, then jumped by 36.79% to $4.6 million in 2023, then surged by 162.22% to $12.1 million in 2024, then fell by 10.42% to $10.9 million in 2025.
• The last three Short term Debt figures came in at $10.9 million (Q4 2025), $11.3 million (Q3 2025), and $12.0 million (Q2 2025), per Business Quant data.